[A 59-year old patient with herpes zoster V1-V2].
Hartsleben
C Hausmann
CH
Medizinische Universitätspoliklinik, Departement Innere Medizin, Kantonsspital, Basel.
D015075:2-Aminopurine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000212:Acyclovir / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000284:Administration, Oral; D000367:Age Factors; D000368:Aged; D000998:Antiviral Agents / Q000008:administration & dosage / Q000627:therapeutic use; D000077595:Famciclovir; D006563:Herpes Zoster Ophthalmicus / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy; D006801:Humans; D008297:Male; D008875:Middle Aged; D009824:Ointments; D013997:Time Factors; D012668:Trigeminal Ganglion; D014276:Trigeminal Nerve; D000077483:Valacyclovir; D014633:Valine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use
D000998:Antiviral Agents; D009824:Ointments; D015075:2-Aminopurine; D014633:Valine; D000077483:Valacyclovir; D000077595:Famciclovir; D000212:Acyclovir
59-jähriger Patient mit Herpes zoster V1-V2.